/
/
/

Gujarat Themis Biosyn Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Sep 2025Jun 2025
₹50 Cr₹44 Cr₹42 Cr₹36 Cr
₹4 Cr₹13 L₹82 L₹27 L
₹54 Cr₹44 Cr₹43 Cr₹36 Cr
₹55 Cr₹27 Cr₹24 Cr₹24 Cr
₹3 Cr₹21 Cr₹22 Cr₹14 Cr
₹8 Cr₹2 Cr₹4 L₹4 L
-₹11 Cr₹15 Cr₹19 Cr₹12 Cr
-₹14 Cr₹11 Cr₹14 Cr₹9 Cr

Share Price Live Stats

Open (₹)359.25
Volume (₹)19,862.00
High (₹)365.00
Upper Circuit431.10
Low (₹)359.25
Lower Circuit287.40
Prev Close359.25
52W High (₹)470.05
Price364.00
52W Low (₹)225.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)4681.56 Cr
Div. Yield (%)0.19
PE Ratio109.16
Debt to Equity0.56
Price to Book8.61
Book Value26.41
EPS (TTM)3.30
Face Value1.00
ROE (%)17.41

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GUJTHEMNSE
LTP
1W Low
1W High
Market cap (₹)
1875.2-9.8 (-0.52%)
1856.80
1915
4,47,944Cr
11076.5-408.5 (-3.56%)
10954
11645.50
2,94,962Cr
4675.5-51.7 (-1.09%)
4651.10
4741.70
1,78,391Cr
2258.7-141.3 (-5.89%)
2190
2446.90
1,19,790Cr
1204.6-1.4 (-0.12%)
1181.10
1213
1,18,603Cr
1370.6-16 (-1.15%)
1368.70
1404
1,15,267Cr
1395.1-13.2 (-0.94%)
1383.80
1418.70
1,12,620Cr
2631.3-7.3 (-0.28%)
2612.20
2694
1,08,424Cr
1801.4-5.8 (-0.32%)
1783
1849.30
1,02,878Cr
1968.9-46.1 (-2.29%)
1960.20
2027
90,201Cr
364-23.55 (-6.08%)
357
392.35
4,682Cr
Empty box

No content available